ISIN | CH0506063244 |
---|---|
Valor Number | 50606324 |
Bloomberg Global ID | |
Fund Name | UBAM (CH) - Swiss Equity (CHF) I |
Fund Provider |
Union Bancaire Privée, UBP SA
Genève 1, Switzerland Phone: +41 22 819 28 00 E-Mail: ubpfunds@ubp.com Web: www.ubp.com |
Fund Provider | Union Bancaire Privée, UBP SA |
Representative in Switzerland | |
Distributor(s) |
Banque Cantonale Vaudoise Lausanne Phone: +41 21 212 10 00 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The Swiss Equity sub-fund aims in the medium term, to generate superior returns relative to the Swiss equity market as measured by the SPI® index. The sub-fund is actively managed and the companies are chosen after a rigorous and diverse selection process. No guarantee can be given as to the achievement of the sub-fund's investment objective. |
Peculiarities |
Current Price * | 116.14 CHF | 20.02.2025 |
---|---|---|
Previous Price * | 116.12 CHF | 19.02.2025 |
52 Week High * | 117.23 CHF | 13.02.2025 |
52 Week Low * | 102.10 CHF | 22.02.2024 |
NAV * | 116.14 CHF | 20.02.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 13,240,551 | |
Unit/Share Assets *** | 12,830,877 | |
Trading Information SIX |
YTD Performance | +7.98% |
31.12.2024 - 20.02.2025
31.12.2024 20.02.2025 |
---|---|---|
1 month | +4.51% |
20.01.2025 - 20.02.2025
20.01.2025 20.02.2025 |
3 months | +7.72% |
20.11.2024 - 20.02.2025
20.11.2024 20.02.2025 |
6 months | +2.52% |
20.08.2024 - 20.02.2025
20.08.2024 20.02.2025 |
1 year | +13.67% |
20.02.2024 - 20.02.2025
20.02.2024 20.02.2025 |
2 years | +16.20% |
20.02.2023 - 20.02.2025
20.02.2023 20.02.2025 |
3 years | +5.55% |
21.02.2022 - 20.02.2025
21.02.2022 20.02.2025 |
5 years | +13.92% |
20.02.2020 - 20.02.2025
20.02.2020 20.02.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Roche Holding AG | 11.51% | |
---|---|---|
Nestle SA | 10.95% | |
Novartis AG Registered Shares | 9.10% | |
ABB Ltd | 7.30% | |
UBS Group AG | 5.40% | |
Alcon Inc | 4.10% | |
Zurich Insurance Group AG | 3.86% | |
Sika AG | 3.10% | |
Accelleron Industries AG Ordinary Shares | 3.04% | |
Lonza Group Ltd | 3.03% | |
Last data update | 31.10.2024 |
TER | 0.90% |
---|---|
TER date | 31.10.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.00% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 31.01.2025 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |